“Modeling and simulation of cancer immunoprevention vaccine” by F.Pappalardo et al Summary by Dhondup Pemba SoCalBSI.

Slides:



Advertisements
Similar presentations
 Used to manufacture recombinant protein.  Ex. Epogen, a protein that boosts RBC production. › Used to treat anemia.
Advertisements

Response Optimization in Oncology In Vivo Studies: a Multiobjective Modeling Approach Maksim Pashkevich, PhD (Early Phase Oncology Statistics) Joint work.
Achieving Equilibrium Team: Borden, Garrison, Holley, Malaugh, Mayer.
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
Simulation of Biological Systems using Dynetica. Dynetica is a simulation tool It can be downloaded for free from the web (
Does immunodominance maintain the diversity of the common cold? William Koppelman University of Utah Master’s Oral Examination.
The Trees for the Forest A Discrete Cell Model of Tumor Growth, Development, and Evolution Ph.D. student in Mathematics/Computational Bioscience Dept.
Triangulation of network metaphors The Royal Netherlands Academy of Arts and Sciences Iina Hellsten & Andrea Scharnhorst Networked Research and Digital.
Nawaf M Albadia Introduction. Components. Behavior & Characteristics. Classes & Rules. Grid Dimensions. Evolving Cellular Automata using Genetic.
VOLTAGE SCHEDULING HEURISTIC for REAL-TIME TASK GRAPHS D. Roychowdhury, I. Koren, C. M. Krishna University of Massachusetts, Amherst Y.-H. Lee Arizona.
RNA Tumor Viruses - The Rous Sarcoma Virus Story
Notes on Modeling with Discrete Particle Systems Audi Byrne July 28 th, 2004 Kenworthy Lab Meeting Deutsch et al.
 Hepatitis C virus (HCV) infects 170 million people worldwide  up to 80% of those infected become chronic infection.  HCV infection can cause chronic.
In Silico Simulation of a Translational Human Breast Cancer Model in Mice March 25 th, 2013 Mark Dawidek Department of Medical Biophysics.
New Treatments. New drug treatments Chronotherapy Lung cancer vaccine Summary.
Viruses Linked With Cancers Mrs. Stewart Medical Interventions Central Magnet School.
Hybrid Model For Prostate Tumorigenesis Maria Audi Byrne, University of South Alabama MMA Florida Chapter Meeting 5:15 – 5:40 PM November 20, 2009.
MA354 Mathematical Modeling T H 2:45 pm– 4:00 pm Dr. Audi Byrne.
Systems Biology ___ Toward System-level Understanding of Biological Systems Hou-Haifeng.
Gene Therapy Clinical Trials. Cancer Gene Therapy Three Basic Approaches. Genetically alter a person's immune cells that are already naturally targeted.
IMMUNOHISTOCHEMICAL EXPRESSION OF MELK IN BREAST CANCER Manieli C*, Saccani S*, Lai ML*, Pilloni L*, Coni PP*, Senes G*, Faa G*, Van den Oord JJ°. *I Cattedra.
In silico gene targeting approach integrating signaling, metabolic, and regulatory networks Bin Song Jan 29, 2009.
MA354 An Introduction to Math Models (more or less corresponding to 1.0 in your book)
Viruses Linked With Cancers. Human Papilloma Viruses (HPVs) HPV is a sexually transmitted infection. HPV causes abnormal cells to start growing and eventually.
A Cellular Automata Model on HIV Infection (2) Shiwu Zhang Based on [Pandey et al’s work]
Learning Chaotic Dynamics from Time Series Data A Recurrent Support Vector Machine Approach Vinay Varadan.
MA354 Math Modeling Introduction. Outline A. Three Course Objectives 1. Model literacy: understanding a typical model description 2. Model Analysis 3.
“Isolation of rare circulating tumour cells in cancer patients by microchip technology” Nagrath et al. Nature 2007 Peter Bojo.
A UNIQUE IN VIVO ASSAY FOR YOUR ONCOLOGY DRUG CANDIDATES Target Validation Efficacy and Toxicity Evaluation Arnaud Peyronnier Business Development Manager.
The role of regulatory B cells on hepatocellular carcinoma progression Conclusion Results Fig2. (A and B) In vivo, Bregs in SCID mice increased the size.
Supermodel of melanoma dynamics Witold Dzwinel 1, Adrian Kłusek 1 and Oleg V. Vasilyev 2 AGH University of Science and Technology, Department of Computer.
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal- cell carcinoma after radical nephrectomy: phase III,
Viruses Linked with Cancer
Viral infections and cancer
HPV VACCINATION ——1st vaccine against cancer
What contribution can automated reasoning make to e-Science?
Cancer as a genetic disease
Advisor: Dr. Bhushan Dharmadikhari2, Co-Advisor: Dr. Prabir Patra1, 3
Corrupted tensional homeostasis accompanies tumor progression.
Mezale D*1, Strumfa I1, Balodis D1, Vanags A2, Rumba R2
Association between Betapapillomavirus Seropositivity and Keratinocyte Carcinoma— Prospects for Prophylactic Vaccination?  Herbert Pfister  Journal of.
Identification of neutral tumor evolution across cancer types
Role of HER2 in mediating acquired resistance to EGFR inhibition.
Highly related T9 and T3 sarcoma cells show distinct tumor growth patterns but similar PD-L1 expression kinetics in vivo. Highly related T9 and T3 sarcoma.
Comparing drug sensitivity predictions from different data types in melanoma and endometrial cancer cell lines. Comparing drug sensitivity predictions.
Single-Dose Neoadjuvant AKT Pathway Inhibitor Reduces Growth of Hepatocellular Carcinoma after Laser Thermal Ablation in a Small Animal Model  Neoadjuvant PI3K/mTOR/AKT inhibitor prior.
PTENP1 serves as a ceRNA in the regulation of tumor growth in RCC
coTCRcys-transduced T cells control tumor growth in vivo.
Augmentation of in vivo CMS5mHE tumor eradication by HER216-30, but not OVA Augmentation of in vivo CMS5mHE tumor eradication by HER216-30, but.
In vivo growth-inhibitory effect of perifosine on bevacizumab-resistant CCC. A, the effect of bevacizumab (BEV) on CCC growth in vivo. In vivo growth-inhibitory.
Matriptase-2 inhibited breast tumor development in vivo.
Histopathology of anal tissue.
Endothelial cells/microvasucles are increased in prostate cancer versus normal tissues. Endothelial cells/microvasucles are increased in prostate cancer.
Induction of a tumor-specific immune response following radiofrequency ablation (RFA). Induction of a tumor-specific immune response following radiofrequency.
ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells, and NK cells. ADU-S100–mediated tumor clearance is dependent on CD4+, CD8+ T cells,
Antitumor effects of celastrol in vitro and in vivo.
MEDI4736 shows antitumor activity in xenograft mouse models of human cancer. MEDI4736 shows antitumor activity in xenograft mouse models of human cancer.
Irradiated whole-cell vaccination with MOC1, but not MOC2, induces immunologic memory. Irradiated whole-cell vaccination with MOC1, but not MOC2, induces.
Establishment of 12 PDX from BRAF inhibitor–progressed patients.
In vivo bioluminescence imaging of primary tumors and tumor metastasis
Comparison of in vivo activity of 4D5scFvZZ and 4D5scFv.
Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.
Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.
Pdcd4 delays and attenuates papilloma development in a dose-dependent manner. Pdcd4 delays and attenuates papilloma development in a dose-dependent manner.
MGA271 exhibits potent in vivo antitumor activity toward tumor cell carcinoma xenografts. MGA271 exhibits potent in vivo antitumor activity toward tumor.
Increased accumulation of pmel-1 T cells to tumor sites and enhanced antitumor immune response in mice receiving ACT combined with anti-PD-1 antibody treatment.
PDL192 and inhibit the growth of xenograft tumors.
Transgenic mice with constitutively active NIK show increased tumor growth in bone. Transgenic mice with constitutively active NIK show increased tumor.
Knockdown of ROR1 increases the invasive potential of melanoma cells in vitro and in vivo. Knockdown of ROR1 increases the invasive potential of melanoma.
Tumor growth in female progeny with prenatal/maternal, postnatal early-life, and postnatal adult BSp dietary administrations. Tumor growth in female progeny.
Presentation transcript:

“Modeling and simulation of cancer immunoprevention vaccine” by F.Pappalardo et al Summary by Dhondup Pemba SoCalBSI

Outline Background Motivation Method Results Conclusion

Background 2:Cancer Immunoprevention Cervical Cancer  Papilloma Vaccination Hepatocellular Carcinoma  Hepatitis B Vaccination Tumors not linked to viruses?

Background 3: In vivo experiment HER2 Transgenic mouse Triplex Vaccine 5 Vaccination Protocols  Early – 6 weeks  Late – 10 weeks  Very late – 16 weeks  Chronic- 6 weeks with repetition  Untreated

Motivation Determining optimal vaccination protocol

Method: Model type Modified Lattice Gas Automata  Class of Dynamical Systems  Particles move in discrete time steps  Stochastic relationship between interacting entities

Method: Internal States

Method: Interactions

Method: Model Algorithm SimTriplex Simulator Initialization Iteration  Interaction Dynamics  Internal Dynamics  Output

Results 1:

Results 2

Results 4

Results 3

Conclusion: Excellent agreement between in vivo and in silico models Important Biological point that can be further examined  Antibodies instead of T cells as the control of tumor growth Future expansion to predict vaccination schedules  Saves time  Money